Really tough to put more $$ into this company. The trial is...

Really tough to put more $$ into this company. The trial is taking forever to get off the ground, nub status in germany is a toss up, the reimbursement question here in the states, interim analysis is hardly a given, they keep talking about the feasibility trial, cp2 is going into yet another cow, the market is destroying this stock, any + news does diddly squat, and - news kills it, conferences have no effect whatsoever, cash burn questions...on and on. Too late to sell now. But, i won't buy any more, either..